Reduction of ¹⁸F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier Detectors

Abstract

Purpose To determine the level of clinically acceptable reduction in injected fluorine 18 ((18)F) fluorodeoxyglucose (FDG) dose in time-of-flight (TOF)-positron emission tomography(PET)/magnetic resonance (MR) imaging by using silicon photomultiplier (SiPM) detectors compared with TOF-PET/computed tomography (CT) using Lu1.8Y0.2SiO5(Ce), or LYSO, detectors in patients with different body mass indexes (BMIs). Materials and Methods Patients were enrolled in this study as part of a larger prospective study with a different purpose than evaluated in this study (NCT02316431). All patients gave written informed consent prior to inclusion into the study. In this study, 74 patients with different malignant diseases underwent sequential whole-body TOF-PET/CT and TOF-PET/MR imaging. PET images with simulated reduction of injected (18)F-FDG doses were generated by unlisting the list-mode data from PET/MR imaging. Two readers rated the image quality of whole-body data sets, as well as the image quality in each body compartment, and evaluated the conspicuity of malignant lesions. Results The image quality with 70% or 60% of the injected dose of (18)F-FDG at PET/MR imaging was comparable to that at PET/CT. With 50% of the injected dose, comparable image quality was maintained among patients with a BMI of less than 25 kg/m(2). PET images without TOF reconstruction showed higher artifact scores and deteriorated sharpness than those with TOF reconstruction. Conclusion Sixty percent of the usually injected (18)F-FDG dose (reduction of up to 40%) in patients with a BMI of more than 25 kg/m(2) results in clinically adequate PET image quality in TOF-PET/MR imaging performed by using SiPM detectors. Additionally, in patients with a BMI of less than 25 kg/m(2), 50% of the injected dose may safely be used. (©) RSNA, 2017 Online supplemental material is available for this article. Purpose:To determine the level of clinically acceptable reduction in injected fluorine 18 ( Materials andMethods:Patients were enrolled in this study as part of a larger prospective study with a different purpose than evaluated in this study (NCT02316431). All patients gave written informed consent prior to inclusion into the study. In this study, 74 patients with different malignant diseases underwent sequential whole-body TOF-PET/CT and TOF-PET/MR imaging. PET images with simulated reduction of injected 18 F-FDG doses were generated by unlisting the list-mode data from PET/MR imaging. Two readers rated the image quality of whole-body data sets, as well as the image quality in each body compartment, and evaluated the conspicuity of malignant lesions. Results:The image quality with 70% or 60% of the injected dose of 18 F-FDG at PET/MR imaging was comparable to that at PET/CT. With 50% of the injected dose, comparable image quality was maintained among patients with a BMI of less than 25 kg/m 2 . PET images without TOF reconstruction showed higher artifact scores and deteriorated sharpness than those with TOF reconstruction. Conclusion:Sixty percent...

Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI

“…Attributed to the new solid-state detector design, increased axial field (29). In a previous study by our group, we showed that when a TOF-capable PET component was used, a dose reduction of up to 50% was feasible in whole-body acquisitions in patients with normal body weight (17).…”

“…New PET technologies used in PET/MRI have been shown to reduce the radiation burden significantly (17), and the PET component of the latest clinical time-of-flight (TOF) PET/MRI system has the potential to reduce radiation exposure even further, especially in single-station imaging. This system uses a new PET detector based on silicon photomultipliers (SiPMs) that offer increased sensitivity compared with conventional PET/CT and PET/MRI scanners, allowing the user to balance dose reduction with acquisition time (18).…”

Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype

“…All patients fasted for at least 4 h prior to the scan. Patients were injected with a standardized dose of 3.5 MBq FDG/kg body weight (analog PET/CT) or a body mass index (BMI)-adjusted FDG dosage protocol (digital PET/CT and PET/MR) (24). All patients had a blood glucose level below 10 mmol/L before imaging.…”

The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases— A simulation study combining multi-center data and ADNI-data

“…First, the data acquisition in patients was heterogeneous and not optimized in all cases for brain PET (short 2 min scan duration and variable post-injection time). Using only 2 min acquisition for brain PET images could limit image quality, despite the use of a state-of-the-art PET/MR scanner with high sensitivity detector [36]. To mitigate this, all images were smoothed with a Gaussian filter of 12 x 12 x 12 mm which step has been included in PALZ as one of the analysis steps.…”